Activity of drugs and components of natural origin in the severe myoclonic epilepsy of infancy (Dravet syndrome)

Central Nervous System Agents in Medicinal Chemistry

Volumn 15, Issue 2, 2015, Pages 95-98

  Berio, Agostino ^a   Piazzi, Attilia ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiepileptic drugs; Cnidaria; SCN 1A mutation; Scn1Lab mutant; SMEI; Zebrafish

Indexed keywords

BENZODIAZEPINE; CLONAZEPAM; CORTICOTROPIN; DIAZEPAM; NEUROTOXIN; PHENOBARBITAL; POLYPEPTIDE; VALPROIC ACID; VOLTAGE GATED SODIUM CHANNEL; ANTICONVULSIVE AGENT; COELENTERATE VENOM; PEPTIDE; SCN1A PROTEIN, HUMAN; SCN1A PROTEIN, ZEBRAFISH; SODIUM CHANNEL NAV1.1; VOLTAGE GATED SODIUM CHANNEL STIMULATING AGENT; ZEBRAFISH PROTEIN;

ARTICLE; AUTOIMMUNITY; BRAIN CORTEX ATROPHY; CASE REPORT; DRUG ACTIVITY; DRUG RESISTANT EPILEPSY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; GENE MUTATION; HUMAN; INFANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SEA ANEMONE; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TONIC CLONIC SEIZURE; ZEBRA FISH; ANIMAL; CHEMISTRY; CLASSIFICATION; CNIDARIA; DISEASE MODEL; DRUG EFFECTS; DRUG RESISTANCE; EPILEPSIES, MYOCLONIC; GENETICS; METABOLISM; MOLECULAR MIMICRY; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY;

ANIMALS; ANTICONVULSANTS; CNIDARIA; CNIDARIAN VENOMS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; HUMANS; INFANT; MICE; MICE, NEUROLOGIC MUTANTS; MOLECULAR MIMICRY; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; PEPTIDES; SEA ANEMONES; VOLTAGE-GATED SODIUM CHANNEL AGONISTS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84930704963     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/1871524915666150430161321     Document Type: Article

References (19)

1. Murphei, R.D.; Zon, L. Small molecule screening in the zebrafish. Methods, 2006, 39, 255-261.
2. Dravet, C. How Dravet syndrome became a model for studying childhood genetic epilepsies. Brain, 2012, 135, 2309-2313.
3. Brunklaus, A.; Ellis, R.; Reavey, E.; Forbes, G.H.; Zuberi, S.M. Prognostic, clinical and demographic features in SCN 1A mutationpositive Dravet syndrome. Brain, 2012, 135, 2329-2336.
4. Berio, A.; Piazzi, A.; Mangiante, G.; Blasi, G.; Campisi, C. Autoanticorpi ed epilessia; casistica personale. Atti dell’88° congresso SIP, 9-11/5/2012.
5. Rhodes, T.H.; Lossin, C.; Vanoye, C.G.; Wang, D.W.; Gorge, A.L. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. PNAS, 2004, 101, 11147-11152.
6. Oakley, J.C.; Kalume, F.; Yu, F.H.; Scheuer, T.; Catteral, W.A. Temperature and age dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. PNAS, 2009, 106, 3994-3999.
7. Baraban, S.C; Dinday, M.T.; Hortopan, G.A. Drug screening in scn 1a zebrafish mutant identifies clamizole aas a potential Dravet syndrome treatment. Nat. Commun., 2013, 4, 2410.
8. Moran, Y.; Gordon, D.; Gurevitz, M. Sea anemone toxins affecting voltage-gated sodium channels. Molecular and evolutionary features. Toxicon, 2009, 54, 1089-1101.
9. Moran, Y.; Genikhovich, G.; Gordon, D.; Wienkoop, S.; Zenkert, C.; Ozbeck, S.; Technau, U.; Gurevitz, M. Neurotoxin localization to ectodermal gland cells uncovers an alternative mechanism of venom delivery in sea anemones. Proc. R. Soc. B, 2012, 279, 1351-1358.
10. Moran, Y.; Cohen, L.; Kahn, R.; Karbat, I.; Gordon, D.; Gurevitz, M. Expression and mutagenesis of the sea anemone toxin Av2 reveals key aminoacid residues important for activity on voltagegated sodium channel. Biochemistry, 2006, 45, 8864-8873.
11. Wilkly, E.; Zaharenko, A.J.; Redaelli, E.; Schiavon, E. Action of sea anemone type 1 neurotoxins on voltage-gated sodiun channel isoforms. Toxicon., 2009, 54, 1102-1111.
12. Catteral, W.A.; Beress, L. Sea anemone toxin and scorpion toxin share a common receptor site associated with the action potential sodium ionophore. J. Biol. Chem., 1978, 253, 7393-7396.
13. Berio, A.; Mangiante, G.; Piazzi, A. Autoimmunity and epilepsy in children. J. Biol. Res. – Boll. Soc. It. Biol. Sper., 2013, 86, 9-11.
14. Ravizza, T.; Gagliardi, B.; Noè, F.; Boer, K.; Aronica, E.; Vezzani, A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis., 2008, 29, 142-160.
15. Mullen, S.A.; Scheffer, I.E. Translational research in epilepsy genetics. Arch. Neurol., 2009, 66, 21-26.
16. Claes, L.; Del Favero, J.; Ceulermans, J.; Lagae, L.; Van Broekhoven, C.; De Jonghe, P. De novo mutations in the sodium channel gene SCN 1A cause SMEI. Amer. J. Hum. Genet., 2001, 68, 1327-1332.
17. Vezzani, A.; Granata, T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia, 2005, 46, 1724-1743.
18. Vezzani, A; French, J.; Bartfal, T; Baram, T.Z. The role of inflammation in epilepsy. Nat. Neurol., 2011, 7, 31-40.
19. Vassilev, P.; Scheuer, T.; Catterall, W.A. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science, 1988, 241, 1658-1661.